Farms.com Home   News

Open Farm Day Hits Portage

Farmers Across Manitoba opened up their farms to the public yesterday for the 10th annual Open Farm Day.
 
Four local groups opened their doors in Portage while a total of 55 other farms were available to explore across Manitoba.
 
Tara Lee Simpson is a co-owner of Farm away Ranch in Portage and one of the Open farms. She says Open Farm Day is important.
 
"There seems to be more questions about where people's food is coming from, and maybe a little bit of it is misinformation out there," says Simpson. "It's nice for people to come and see it in person, and ask questions in person."
 
The three other stops in Portage included Verwey farms offering tours of their dairy, grain and beef farm. Shur-Gro Farm Services offered tours of their business to educate participants about crop production. Farm Away Retreat taught participants about agricultural tourism. The Food Development Centre will be offered tours of their facilities and lab areas.
 
Evan Pepper was one of the many parents who brought their kids out to Open Farm Day. He explains why he brought his family.
Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.